Solum (248070) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
FY2023 revenue reached ₩1,951.1bn, up 15.1% YoY; operating profit rose 104.4% to ₩154.5bn and net income rose 162.8% to ₩119.4bn.
ICT growth more than offset lower electronics-component sales; ESL revenue expanded while electronics-component operating profit declined YoY.
2024 priorities include growing ESL, VS and power modules, advancing new businesses, strengthening technology leadership and manufacturing capability, and expanding revenue and profitability.
Financial highlights
Revenue ₩1,951.1bn vs ₩1,694.5bn YoY; gross profit ₩314.4bn vs ₩208.8bn; operating profit ₩154.5bn vs ₩75.6bn.
Net income ₩119.4bn vs ₩45.4bn; attributable net income ₩120.4bn vs ₩47.3bn; basic EPS ₩2,464 vs ₩954.
EBITDA ₩188.8bn vs ₩108.1bn; operating cash flow ₩336.9bn vs ₩40.9bn.
Cash and cash equivalents were ₩131.9bn at year-end vs ₩106.9bn; total assets were ₩938.6bn vs ₩1,034.3bn.
Outlook and guidance
2024 outlook anticipates growth from ESL, VS, power modules and new businesses despite global economic uncertainty, protectionism and won volatility.
Healthcare plans include wearable TWS using PPG and temperature sensors and EEG-based mental-health solutions, with 2024 mass production targeted.
Second-life battery plans include power banks, small ESS and mobile EV-charging carts, subject to completion of practical certification and testing procedures.
Continued investment in ESL, 3-in-1 boards and ICT R&D supports growth; cost reduction, productivity and premium-product development remain priorities.
Latest events from Solum
- H1 2026 revenue fell to KRW 970.1B, with net income at KRW 10.1B amid margin pressure.248070
Q2 2026 - Q3 2024 revenue and profit declined sharply, but global expansion and new business lines continue.248070
Q3 2024 - H1 2024 revenue and profit fell, but new business investments and financial stability continue.248070
Q2 2024 - Q1 2025 saw KRW 397.4B revenue, KRW 11.5B operating income, and new business expansion.248070
Q1 2025 - Revenue and profit fell YoY, with new investments in healthcare and battery reuse.248070
Q3 2025 - Q1 2026 revenue and net income grew, led by ICT, but customer concentration and litigation risks remain.248070
Q1 2026 - Revenue up, profit down; major expansion, new preferred shares, and legal risks ongoing.248070
Q4 2025 - 2Q25 sales hit a record, ICT surged, but leverage rose and H1 profit declined; cosmetics deal closed.248070
Q2 2025 - 2024 profit fell 67% on lower sales, but SoluM accelerates global and new business expansion.248070
Q4 2024